Report overview
Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.
This report contains market size and forecasts of Pharmaceutics and Novel Drug Delivery Systems in Global, including the following market information:
Global Pharmaceutics and Novel Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutics and Novel Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutics and Novel Drug Delivery Systems include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmaceutics and Novel Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutics and Novel Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein?drug Conjugates
Other
Global Pharmaceutics and Novel Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinic
Cancer Treatment Centers
Others
Global Pharmaceutics and Novel Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutics and Novel Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutics and Novel Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
